Company News
Meet ALLpaQ’s Business Development Managers
At ALLpaQ, we understand that the greatest resource of any successful business is its people, and we’re excited to welcome […]
Jul 16th, 2024
The role of single-use technologies in vaccine development will continue to evolve over the next decade, according to Xavier Derouck of GlaxoSmithKline.
GSK is a “great believer” in single-use systems, Mr Derouck told delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
To ensure single-use technologies are “used to produce vaccines without any risk” to patients, robust risk mitigation strategies needed to be implemented across all rungs of the supply chain, he added.
As such, Mr Derouck forecasted that over the next five to ten years single-use systems would continue moving towards:
Mr Derouck is GSK’s global senior sourcing manager for single-use technology.